Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Genmab
Merus B.V.
Memorial Sloan Kettering Cancer Center
Amgen
University of California, Davis
Washington University School of Medicine
Inhibrx Biosciences, Inc
BicycleTx Limited
Roswell Park Cancer Institute
University of Pittsburgh
Immunitas Therapeutics
Providence Health & Services
Rakuten Medical, Inc.
University of Cincinnati
Klus Pharma Inc.
University of Texas Southwestern Medical Center
Taiho Oncology, Inc.
Suzhou Junde Biotechnology Co., Ltd
Salubris Biotherapeutics Inc
NGM Biopharmaceuticals, Inc
Universitaire Ziekenhuizen KU Leuven
Centre hospitalier de l'Université de Montréal (CHUM)